Platelet serotonin functions in untreated major depression

Psychiatry Research

Volumn 85, Issue 2, 1999, Pages 189-198

  Neuger, Jolanta ^a   El Khoury, A ^a   Kjellman, Bengt F ^a   Wahlund, Bjorn ^a   Åberg Wistedt, Anna ^a   Stain Malmgren, Rigmor ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

5 HT2 receptors; Paroxetine binding sites; Serotonin uptake

Indexed keywords

LYSERGIDE; PAROXETINE; SEROTONIN; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DEPRESSION; FEMALE; HUMAN; ISOTOPE LABELING; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEROTONIN UPTAKE; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; SUICIDAL BEHAVIOR; THROMBOCYTE;

ADULT; AGED; ANALYSIS OF VARIANCE; ANXIETY; BLOOD PLATELETS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, SEROTONIN; REGRESSION ANALYSIS; SEROTONIN; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SUICIDE;

EID: 0033593832     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(99)00006-2     Document Type: Article

References (40)

1. 2 and β-adrenergic receptor binding sites in the brain of suicide victims. Archives of General Psychiatry. 47:1990;1048-11047.
2. Baumgarten H.G., Lachenmayor L. Anatomical features and physiological properties of central serotonergic neurons. Pharmacopsychiatry. 18:1985;180-187.
3. Briley M.S., Langer S.Z., Raisman R., Sechter D., Zarifian E. Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science. 209:1980;303-305.
4. 3H]5-HT uptake: effect of administration of various antidepressant treatments. Neuropharmacology. 32:1993;737-743.
5. Coccaro E.F., Kavoussi R.J., Sheline Y.I., Lish J.D., Csernansky J.G. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet. Archives of General Psychiatry. 53:1996;531-536.
6. Cowen P.J., Charig E.M., Fraser S., Elliott J.M. Platelet 5-HT receptor binding during depressive illness and tricyclic antidepressant treatment. Journal of Affective Disorders. 13:1987;45-50.
7. 3H-paroxetine binding in depressed patients. Psychiatry Research. 26:1988;11-17.
8. 3H]paroxetine to platelets of depressed patients: seasonal differences and effects of diagnostic classification. Journal of Affective Disorders. 32:1994;27-35.
9. 3H]paroxetine binding in healthy volunteers. Neuropsychopharmacology. 15:1996;187-198.
10. 125I]iodolysergic acid diethylamine binding in frontal cortex and platelet tissue. Journal of Neurochemistry. 53:1989;191-196.
11. 3H-serotonin uptake in blood platelets in major depressive episodes. Biological Psychiatry. 23:1988;833-836.
12. Fichtner C.G., Arora R.C., O'Connor F.L., Crayton J.W. Platelet paroxetine binding and fluoxetine pharmacotherapy in posttraumatic stress disorder: preliminary observations on a possible predictor of clinical treatment response. Life Sciences. 55:1994;39-44.
13. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry. 23:1960;56-62.
14. 2 sites in cortex and amygdala. Brain Research. 614:1993;37-44.
15. 2 receptors. Journal of Psychiatry and Neuroscience. 20:1995;11-19.
16. 3H]paroxetine binding on human platelets. Biological Psychiatry. 36:1994;281-291.
17. 3H]paroxetine to blood platelets in healthy volunteers. Indications for a gender difference. Biological Psychiatry. 28:1990;509-517.
18. 3H]paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine. Psychopharmacology. 115:1994;261-264.
19. Lesch K.P., Wolozin B.L., Murphy D.L., Riederer P.P. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. Journal of Neurochemistry. 60:1993;2319-2322.
20. Maes, M., Meltzer, H.Y., 1995. The serotonin hypothesis of major depression. In: Bloom, F.E., Kupfer, D.J., (Eds.), Psychopharmacology, the Fourth Generation of Progress. Raven Press, New York, pp. 933-944.
21. 3H-paroxetine binding to platelets from healthy volunteers. Biological Psychiatry. 34:1993;356-360.
22. Malmgren R. Platelets and biogenic amines. 1. Platelets are poor investigative models for dopamine reuptake. Psychopharmacology. 84:1984;480-485.
23. Malmgren R., Åberg-Wistedt A., Mårtensson B. Aberrant seasonal variations of platelet serotonin uptake in endogenous depression. Biological Psychiatry. 25:1989;303-402.
24. McBride P.A., Mann J.J., McEwen B., Biegon A. Characterization of serotonin binding sites on human platelets. Life Sciences. 33:1983;2033-2041.
25. 2-receptor indices to major depression disorder, personality traits and suicidal behavior. Biological Psychiatry. 35:1994;295-308.
26. 3H]imipramine to rat neuronal membranes. Psychopharmacology. 89:1986;436-439.
27. Mellerup E.T., Errebo I., Molin J., Plenge P., Dam H. Platelet paroxetine binding and light therapy in winter depression. Journal of Affective Disorders. 29:1993;11-15.
28. Meltzer H.Y., Arora R.C. Genetic control of serotonin uptake in blood platelets: a twin study. Psychiatry Research. 24:1988;263-269.
29. Montgomery S.A., Åsberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry. 134:1979;382-389.
30. 3H-paroxetine binding in control subjects and depressed patients: relationship to serotonin uptake and age. Psychiatry Research. 51:1994;147-155.
31. Nemeroff C.B., Knight D.L., Franks J., Craighead W.E., Krishnan K.R. Further studies on platelet serotonin transporter binding in depression. American Journal of Psychiatry. 151:1994;1623-1625.
32. th ECNP Congress of Neuro-psychopharmacology in Vienna, Austria.
33. Neuger et al., 1999, in press.
34. Pandey G.N., Pandey S.C., Janicak P.G., Marks R.C., Davis J.M. Platelet serotonin-2 receptor binding sites in depression and suicide. Biological Psychiatry. 28:1990;215-222.
35. Pandey G.N., Pandey S.C., Dwivedi Y., Sharma R.P., Janicak P.G., Davis J.M. Platelet serotonin-2A receptors: a potential biological marker for suicidal behavior. American Journal of Psychiatry. 153:1995;850-855.
36. 3H]lyseric acid diethylamide binding to human platelets. In: Hawiger, J.J., (ed.), Methods in Enzymology Vol 215, part B, Academic Press Inc., 201-213.
37. Sheline Y.I., Bardgett M.E., Jackson J.L., Newcomer J.W., Csernansky J.G. Platelet serotonin markers and depressive symptomatology. Biological Psychiatry. 37:1995;442-447.
38. Smith P.K., Krohn R.I., Hermansson G.T., Mallia A.K., Gartner F.H., Provensano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Annals of Biochemistry. 150:1985;76-85.
39. Tuomisto J., Tukiainen E., Ahlfors U.G. Decreased uptake of 5-hydroxytryptamine in blood platelets from patients with endogenous depression. Psychopharmacology. 65:1979;141-147.
40. Zivin J.A., Waud R.D. Minireview. How to analyse binding, enzyme and uptake data: the simplest case, a single phase. Life Sciences. 30:1982;1407-1422.